C
Christopher P. Irwin
Researcher at Medtronic plc
Publications - 4
Citations - 787
Christopher P. Irwin is an academic researcher from Medtronic plc. The author has contributed to research in topics: Epilepsy & Randomized controlled trial. The author has an hindex of 4, co-authored 4 publications receiving 529 citations.
Papers
More filters
Journal ArticleDOI
Long-term efficacy and safety of thalamic stimulation for drug-resistant partial epilepsy
Vicenta Salanova,Thomas C. Witt,Robert M. Worth,Thomas R. Henry,Robert E. Gross,Jules M. Nazzaro,Douglas Labar,Michael R. Sperling,Ashwini Sharan,Evan Sandok,Adrian Handforth,John M. Stern,Steve Chung,Jaimie M. Henderson,Jacqueline A. French,Gordon H. Baltuch,William E. Rosenfeld,Paul A. Garcia,Nicholas M. Barbaro,Nathan B. Fountain,W. Jeffrey Elias,Robert R. Goodman,John R. Pollard,Alexander I. Tröster,Christopher P. Irwin,Kristin Lambrecht,Nina M. Graves,Robert S. Fisher +27 more
TL;DR: This long-term follow-up provides Class IV evidence that for patients with drug-resistant partial epilepsy, anterior thalamic stimulation is associated with a 69% reduction in seizure frequency and a 34% serious device-related adverse event rate at 5 years.
Journal ArticleDOI
The SANTÉ study at 10 years of follow-up: Effectiveness, safety, and sudden unexpected death in epilepsy.
Vicenta Salanova,Michael R. Sperling,Robert E. Gross,Christopher P. Irwin,Jim A Vollhaber,Jonathon E. Giftakis,Robert S. Fisher +6 more
TL;DR: In this article, the authors evaluated the efficacy and safety of deep brain anterior thalamus stimulation after 7 and 10 years, and reported the incidence of sudden unexpected death in epilepsy (SUDEP) and overall mortality in adults in the Stimulation of the Anterior Nucleus of the Thalamus for Epilepsy (SANTE) study.
Journal ArticleDOI
Memory and mood outcomes after anterior thalamic stimulation for refractory partial epilepsy
TL;DR: Bilateral ANT DBS was associated with subjective depression and memory AEs during the blinded phase in a minority of patients that were not accompanied by objective, long-term neurobehavioral worsening.
Journal ArticleDOI
Spinal cord stimulation therapy for patients with refractory angina who are not candidates for revascularization.
Douglas P. Zipes,Nelson Svorkdal,Daniel S. Berman,Richard L. Boortz-Marx,Timothy D. Henry,Amir Lerman,Edgar L. Ross,Michael S. Turner,Christopher P. Irwin +8 more
TL;DR: The aim of this study was to evaluate the safety and efficacy of spinal cord stimulation (SCS) for refractory angina.